APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucella Melitensis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Brucella Melitensis Vaccine Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchBrucella Melitensis Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucella Melitensis Vaccine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Brucella Melitensis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucella Melitensis Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucella Melitensis Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Brucella Melitensis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Brucella Melitensis Vaccine include Jinyu, VETAL Animal Health Products Inc., Onderstepoort, MSD Animal Health, JOVAC, Hester Biosciences Limited, Dollvet, CZ Veterinaria and Antigen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Brucella Melitensis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Brucella Melitensis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Brucella Melitensis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Brucella Melitensis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Brucella Melitensis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Brucella Melitensis Vaccine Market by Company

Jinyu

VETAL Animal Health Products Inc.

Onderstepoort

MSD Animal Health

JOVAC

Hester Biosciences Limited

Dollvet

CZ Veterinaria

Antigen

Brucella Melitensis Vaccine Segment by Type

Live Vaccines

Attenuated Vaccines

Brucella Melitensis Vaccine Segment by Application

Commercial Farming Enterprise

Private Farming

Brucella Melitensis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Melitensis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucella Melitensis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Melitensis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brucella Melitensis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Brucella Melitensis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Vaccines Table 2. Major Company of Attenuated Vaccines Table 3. Global Brucella Melitensis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Brucella Melitensis Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Brucella Melitensis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Brucella Melitensis Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Brucella Melitensis Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Brucella Melitensis Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Brucella Melitensis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Brucella Melitensis Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Brucella Melitensis Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Brucella Melitensis Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Brucella Melitensis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Brucella Melitensis Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Brucella Melitensis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Brucella Melitensis Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Brucella Melitensis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Brucella Melitensis Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Brucella Melitensis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Brucella Melitensis Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Brucella Melitensis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Brucella Melitensis Vaccine Industry Trends Table 25. Brucella Melitensis Vaccine Industry Drivers Table 26. Brucella Melitensis Vaccine Industry Opportunities and Challenges Table 27. Brucella Melitensis Vaccine Industry Restraints Table 28. Global Brucella Melitensis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Brucella Melitensis Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Brucella Melitensis Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Brucella Melitensis Vaccine Sales Share by Company (2021-2026) Table 32. Global Brucella Melitensis Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Brucella Melitensis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Brucella Melitensis Vaccine Major Company Production Sites and Headquarters Table 35. Global Brucella Melitensis Vaccine Company, Product Type & Application Table 36. Global Brucella Melitensis Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Brucella Melitensis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Brucella Melitensis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Brucella Melitensis Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Brucella Melitensis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Brucella Melitensis Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Brucella Melitensis Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Brucella Melitensis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Brucella Melitensis Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Brucella Melitensis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Brucella Melitensis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Brucella Melitensis Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Brucella Melitensis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Brucella Melitensis Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Brucella Melitensis Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Brucella Melitensis Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Brucella Melitensis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Brucella Melitensis Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Brucella Melitensis Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Brucella Melitensis Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Brucella Melitensis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Brucella Melitensis Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Brucella Melitensis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Brucella Melitensis Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Brucella Melitensis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Brucella Melitensis Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Brucella Melitensis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Brucella Melitensis Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Brucella Melitensis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Jinyu Company Information Table 72. Jinyu Business Overview Table 73. Jinyu Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Jinyu Brucella Melitensis Vaccine Product Portfolio Table 75. Jinyu Recent Development Table 76. VETAL Animal Health Products Inc. Company Information Table 77. VETAL Animal Health Products Inc. Business Overview Table 78. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Portfolio Table 80. VETAL Animal Health Products Inc. Recent Development Table 81. Onderstepoort Company Information Table 82. Onderstepoort Business Overview Table 83. Onderstepoort Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Onderstepoort Brucella Melitensis Vaccine Product Portfolio Table 85. Onderstepoort Recent Development Table 86. MSD Animal Health Company Information Table 87. MSD Animal Health Business Overview Table 88. MSD Animal Health Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. MSD Animal Health Brucella Melitensis Vaccine Product Portfolio Table 90. MSD Animal Health Recent Development Table 91. JOVAC Company Information Table 92. JOVAC Business Overview Table 93. JOVAC Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. JOVAC Brucella Melitensis Vaccine Product Portfolio Table 95. JOVAC Recent Development Table 96. Hester Biosciences Limited Company Information Table 97. Hester Biosciences Limited Business Overview Table 98. Hester Biosciences Limited Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Hester Biosciences Limited Brucella Melitensis Vaccine Product Portfolio Table 100. Hester Biosciences Limited Recent Development Table 101. Dollvet Company Information Table 102. Dollvet Business Overview Table 103. Dollvet Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Dollvet Brucella Melitensis Vaccine Product Portfolio Table 105. Dollvet Recent Development Table 106. CZ Veterinaria Company Information Table 107. CZ Veterinaria Business Overview Table 108. CZ Veterinaria Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. CZ Veterinaria Brucella Melitensis Vaccine Product Portfolio Table 110. CZ Veterinaria Recent Development Table 111. Antigen Company Information Table 112. Antigen Business Overview Table 113. Antigen Brucella Melitensis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Antigen Brucella Melitensis Vaccine Product Portfolio Table 115. Antigen Recent Development Table 116. North America Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 118. North America Brucella Melitensis Vaccine Sales Market Share by Country (2021-2026) Table 119. North America Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Brucella Melitensis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Brucella Melitensis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Brucella Melitensis Vaccine Market Share by Country (2021-2026) Table 124. North America Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Brucella Melitensis Vaccine Market Share Forecast by Country (2027-2032) Table 126. Europe Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 128. Europe Brucella Melitensis Vaccine Sales Market Share by Country (2021-2026) Table 129. Europe Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Brucella Melitensis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Brucella Melitensis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Brucella Melitensis Vaccine Market Share by Country (2021-2026) Table 134. Europe Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Brucella Melitensis Vaccine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Brucella Melitensis Vaccine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Brucella Melitensis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Brucella Melitensis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Brucella Melitensis Vaccine Market Share by Country (2021-2026) Table 144. Asia-Pacific Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Brucella Melitensis Vaccine Market Share Forecast by Country (2027-2032) Table 146. Latin America Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 148. Latin America Brucella Melitensis Vaccine Sales Market Share by Country (2021-2026) Table 149. Latin America Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Brucella Melitensis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Brucella Melitensis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Brucella Melitensis Vaccine Market Share by Country (2021-2026) Table 154. Latin America Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Brucella Melitensis Vaccine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Brucella Melitensis Vaccine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Brucella Melitensis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Brucella Melitensis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Brucella Melitensis Vaccine Market Share by Country (2021-2026) Table 164. Middle East and Africa Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Brucella Melitensis Vaccine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Brucella Melitensis Vaccine Distributors List Table 169. Brucella Melitensis Vaccine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Brucella Melitensis Vaccine Image Figure 2. Global Brucella Melitensis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucella Melitensis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Brucella Melitensis Vaccine Sales (2021-2032) & (k units) Figure 5. Live Vaccines Image Figure 6. Global Live Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Attenuated Vaccines Image Figure 8. Global Attenuated Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Brucella Melitensis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Brucella Melitensis Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Brucella Melitensis Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Brucella Melitensis Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Brucella Melitensis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Brucella Melitensis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Brucella Melitensis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Brucella Melitensis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Brucella Melitensis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Brucella Melitensis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Brucella Melitensis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Brucella Melitensis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Brucella Melitensis Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Commercial Farming Enterprise Image Figure 24. Global Commercial Farming Enterprise Sales YoY Growth (2021-2032) & (k units) Figure 25. Private Farming Image Figure 26. Global Private Farming Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Brucella Melitensis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Brucella Melitensis Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Brucella Melitensis Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Brucella Melitensis Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Brucella Melitensis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Brucella Melitensis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Brucella Melitensis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Brucella Melitensis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Brucella Melitensis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Brucella Melitensis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Brucella Melitensis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Brucella Melitensis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Brucella Melitensis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Brucella Melitensis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Brucella Melitensis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Brucella Melitensis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Brucella Melitensis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Brucella Melitensis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Brucella Melitensis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Brucella Melitensis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Brucella Melitensis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Brucella Melitensis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Brucella Melitensis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Brucella Melitensis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Brucella Melitensis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Brucella Melitensis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Brucella Melitensis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Brucella Melitensis Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Brucella Melitensis Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Attenuated Vaccines
Applications
  • Commercial Farming Enterprise
  • Private Farming
Companies covered
  • Jinyu
  • VETAL Animal Health Products Inc.
  • Onderstepoort
  • MSD Animal Health
  • JOVAC
  • Hester Biosciences Limited
  • Dollvet
  • CZ Veterinaria
  • Antigen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Brucella Melitensis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Brucella Melitensis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Brucella Melitensis Vaccine Market by Type
  6. 1.3.1 Live Vaccines
  7. 1.3.2 Attenuated Vaccines
  8. 1.4 Global Brucella Melitensis Vaccine Market Size by Type
  9. 1.4.1 Global Brucella Melitensis Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Brucella Melitensis Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Brucella Melitensis Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Brucella Melitensis Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Brucella Melitensis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Brucella Melitensis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Brucella Melitensis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Brucella Melitensis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Brucella Melitensis Vaccine Industry Trends
  2. 2.2 Brucella Melitensis Vaccine Industry Drivers
  3. 2.3 Brucella Melitensis Vaccine Industry Opportunities and Challenges
  4. 2.4 Brucella Melitensis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Brucella Melitensis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Brucella Melitensis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Brucella Melitensis Vaccine Price (2021-2026)
  4. 3.4 Global Brucella Melitensis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brucella Melitensis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Brucella Melitensis Vaccine Company, Product Type & Application
  7. 3.7 Global Brucella Melitensis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brucella Melitensis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brucella Melitensis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brucella Melitensis Vaccine Tier 1, Tier 2, and Tier 3
4 Brucella Melitensis Vaccine Regional Status and Outlook
  1. 4.1 Global Brucella Melitensis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Brucella Melitensis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Brucella Melitensis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Brucella Melitensis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Brucella Melitensis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Brucella Melitensis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Brucella Melitensis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Brucella Melitensis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Brucella Melitensis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Brucella Melitensis Vaccine by Application
  1. 5.1 Brucella Melitensis Vaccine Market by Application
  2. 5.1.1 Commercial Farming Enterprise
  3. 5.1.2 Private Farming
  4. 5.2 Global Brucella Melitensis Vaccine Market Size by Application
  5. 5.2.1 Global Brucella Melitensis Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Brucella Melitensis Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Brucella Melitensis Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Brucella Melitensis Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Brucella Melitensis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Brucella Melitensis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Brucella Melitensis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Brucella Melitensis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jinyu
  2. 6.1.1 Jinyu Company Information
  3. 6.1.2 Jinyu Business Overview
  4. 6.1.3 Jinyu Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jinyu Brucella Melitensis Vaccine Product Portfolio
  6. 6.1.5 Jinyu Recent Developments
  7. 6.2 VETAL Animal Health Products Inc.
  8. 6.2.1 VETAL Animal Health Products Inc. Company Information
  9. 6.2.2 VETAL Animal Health Products Inc. Business Overview
  10. 6.2.3 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Portfolio
  12. 6.2.5 VETAL Animal Health Products Inc. Recent Developments
  13. 6.3 Onderstepoort
  14. 6.3.1 Onderstepoort Company Information
  15. 6.3.2 Onderstepoort Business Overview
  16. 6.3.3 Onderstepoort Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Onderstepoort Brucella Melitensis Vaccine Product Portfolio
  18. 6.3.5 Onderstepoort Recent Developments
  19. 6.4 MSD Animal Health
  20. 6.4.1 MSD Animal Health Company Information
  21. 6.4.2 MSD Animal Health Business Overview
  22. 6.4.3 MSD Animal Health Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MSD Animal Health Brucella Melitensis Vaccine Product Portfolio
  24. 6.4.5 MSD Animal Health Recent Developments
  25. 6.5 JOVAC
  26. 6.5.1 JOVAC Company Information
  27. 6.5.2 JOVAC Business Overview
  28. 6.5.3 JOVAC Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 JOVAC Brucella Melitensis Vaccine Product Portfolio
  30. 6.5.5 JOVAC Recent Developments
  31. 6.6 Hester Biosciences Limited
  32. 6.6.1 Hester Biosciences Limited Company Information
  33. 6.6.2 Hester Biosciences Limited Business Overview
  34. 6.6.3 Hester Biosciences Limited Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hester Biosciences Limited Brucella Melitensis Vaccine Product Portfolio
  36. 6.6.5 Hester Biosciences Limited Recent Developments
  37. 6.7 Dollvet
  38. 6.7.1 Dollvet Company Information
  39. 6.7.2 Dollvet Business Overview
  40. 6.7.3 Dollvet Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dollvet Brucella Melitensis Vaccine Product Portfolio
  42. 6.7.5 Dollvet Recent Developments
  43. 6.8 CZ Veterinaria
  44. 6.8.1 CZ Veterinaria Company Information
  45. 6.8.2 CZ Veterinaria Business Overview
  46. 6.8.3 CZ Veterinaria Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CZ Veterinaria Brucella Melitensis Vaccine Product Portfolio
  48. 6.8.5 CZ Veterinaria Recent Developments
  49. 6.9 Antigen
  50. 6.9.1 Antigen Company Information
  51. 6.9.2 Antigen Business Overview
  52. 6.9.3 Antigen Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Antigen Brucella Melitensis Vaccine Product Portfolio
  54. 6.9.5 Antigen Recent Developments
7 North America by Country
  1. 7.1 North America Brucella Melitensis Vaccine Sales by Country
  2. 7.1.1 North America Brucella Melitensis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Brucella Melitensis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Brucella Melitensis Vaccine Market Size by Country
  6. 7.2.1 North America Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Brucella Melitensis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Brucella Melitensis Vaccine Sales by Country
  2. 8.1.1 Europe Brucella Melitensis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Brucella Melitensis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Brucella Melitensis Vaccine Market Size by Country
  6. 8.2.1 Europe Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Brucella Melitensis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Brucella Melitensis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Brucella Melitensis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Brucella Melitensis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Brucella Melitensis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Brucella Melitensis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Brucella Melitensis Vaccine Sales by Country
  2. 10.1.1 South America Brucella Melitensis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Brucella Melitensis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Brucella Melitensis Vaccine Market Size by Country
  6. 10.2.1 South America Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Brucella Melitensis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Brucella Melitensis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Brucella Melitensis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Brucella Melitensis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Brucella Melitensis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Brucella Melitensis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Brucella Melitensis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Brucella Melitensis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Brucella Melitensis Vaccine Value Chain Analysis
  2. 12.1.1 Brucella Melitensis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Brucella Melitensis Vaccine Production Mode & Process
  7. 12.2 Brucella Melitensis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Brucella Melitensis Vaccine Distributors
  10. 12.2.3 Brucella Melitensis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst